Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects (DDI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01707407
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : December 4, 2012
Sponsor:
Information provided by (Responsible Party):
Celgene ( Celgene Corporation )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2012
Actual Study Completion Date : November 2012